Stockholders’ Equity - Warrants Narrative (Details) - Vendor Warrants $ / shares in Units, $ in Millions |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
USD ($)
$ / shares
shares
| |
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Outstanding (in shares) | 271,962 |
| Exercisable (in shares) | 271,962 |
| Exercisable and outstanding (in dollars per share) | $ / shares | $ 1.75 |
| Exercisable and outstanding (in years) | 7 years 3 days |
| Exercisable and outstanding, intrinsic value | $ | $ 5.2 |
| Class of warrant or right, number securities called by warrants or rights (in shares) | 26,603 |
| X | ||||||||||
- Definition Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable and Outstanding, Aggregate Intrinsic Value No definition available.
|
| X | ||||||||||
- Definition Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable and Outstanding, Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable and Outstanding, Weighted Average Remaining Contractual Terms No definition available.
|
| X | ||||||||||
- Definition Share-based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Exercisable No definition available.
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|